Western Financial Corp CA purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 15,953 shares of the biotechnology company’s stock, valued at approximately $6,740,000. Axon Enterprise makes up 2.2% of Western Financial Corp CA’s portfolio, making the stock its 6th largest position.
A number of other hedge funds have also added to or reduced their stakes in AXON. State Street Corp lifted its stake in Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after purchasing an additional 209,879,882 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of Axon Enterprise by 18,050.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after purchasing an additional 13,127,348 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Axon Enterprise by 8,432.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after purchasing an additional 3,496,493 shares during the last quarter. Nykredit A S bought a new position in shares of Axon Enterprise in the 2nd quarter valued at $698,937,000. Finally, Mn Services Vermogensbeheer B.V. raised its holdings in shares of Axon Enterprise by 5,571.4% during the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 1,262,110 shares of the biotechnology company’s stock worth $533,267,000 after buying an additional 1,239,856 shares in the last quarter. 79.08% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the company’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president owned 296,974 shares in the company, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. The trade was a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 47,397 shares of company stock valued at $26,722,984 in the last quarter. 4.20% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Axon Enterprise
Axon Enterprise Trading Down 1.2%
NASDAQ AXON traded down $4.93 on Wednesday, hitting $408.42. The company’s stock had a trading volume of 1,038,261 shares, compared to its average volume of 1,050,676. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $764.02. The company’s 50-day moving average is $511.34 and its 200 day moving average is $475.41. The firm has a market cap of $33.18 billion, a PE ratio of 169.47, a PEG ratio of 7.80 and a beta of 1.44.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company’s revenue for the quarter was up 35.3% on a year-over-year basis. During the same quarter last year, the firm earned $2.12 earnings per share. As a group, analysts predict that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.
About Axon Enterprise
Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.
The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.
Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
